SIBNSI-BONE, Inc.

$615M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$22M+58.0% YoY

Gross Profit

$20M89.3% margin

Operating Income

-$13M-58.4% margin

Net Income

-$14M-63.0% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+8.6%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$10M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$207M

Total Liabilities

$53M

Stockholders' Equity

$154M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$14M	+58.0%
Gross Profit	$20M	$12M	+66.1%
Operating Income	-$13M	-$10M	-27.9%
Net Income	-$14M	-$12M	-12.1%

Geographic Segments

UNITED STATES

$20M91%

Non-US

$2M9%

SIBN Q2 2021 Earnings — SI-BONE, Inc. Revenue & Financial Results | Market Cap Arena